Mbp Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 09-07-2024
- Paid Up Capital ₹ 1.50 Cr
as on 09-07-2024
- Company Age 17 Year, 11 Months
- Last Filing with ROC 31 Mar 2013
- Open Charges ₹ 1.00 Cr
as on 09-07-2024
About Mbp Pharmaceuticals
The Corporate was formerly known as Mjs Builders & Promoters Private Limited. The Company is engaged in the Real Estate And Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2013. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.50 Cr.
The company currently has active open charges totaling ₹1.00 Cr.
Jagjit Chahal and Paramjit Singh serve as directors at the Company.
- CIN/LLPIN
U70102PB2007PTC030834
- Company No.
030834
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jan 2007
- Date of AGM
30 Sep 2013
- Date of Balance Sheet
31 Mar 2013
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Ludhiana, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Mbp Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagjit Chahal  | Director | 22-Jan-2007 | Current |
| Paramjit Singh | Additional Director | 13-Feb-2009 | Current |
Financial Performance of Mbp Pharmaceuticals.
Enhance accessibility to Mbp Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Mbp Pharmaceuticals?
Unlock access to Mbp Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Tulip Formulations Private LimitedActive 19 years 4 monthsJagjit Chahal and Paramjit Singh are mutual person
- Chahal Tyreworld Private LimitedActive 23 years 5 months
Jagjit Chahal and Paramjit Singh are mutual person
- New Piyar Roadways Private LimitedActive 27 years 4 months
Jagjit Chahal and Paramjit Singh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 15 May 2009 | ₹1.00 Cr | Open |
How Many Employees Work at Mbp Pharmaceuticals?
Unlock and access historical data on people associated with Mbp Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mbp Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mbp Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
